NIH-funded research R01 grant

Reducing brain fluid buildup after bleeding in premature infants

Official title: Targeting the Choroid Plexus-Cerebrospinal Fluid System to Treat Post-Hemorrhagic Hydrocephalus

Funded at Boston Children's Hospital · NIH-11248423 · Data updated 2026-11-12

This project tests whether changing how the brain's choroid plexus handles salt and water and how immune cells clear blood can prevent fluid buildup in premature babies after brain bleeding.

More Hydrocephalus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston Children's Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2027
Funding year2026
Award (this year)$582,811
NIH project number5R01NS129823-04
Project IDNIH-11248423 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are premature infants who have experienced intraventricular hemorrhage and are at risk of developing post-hemorrhagic hydrocephalus.

Less likely to help

Adults or patients without recent intraventricular bleeding are unlikely to benefit from this infant-focused research.

What this research studies

Researchers are working to understand why some premature infants develop post-hemorrhagic hydrocephalus (PHH) after intraventricular bleeding. They will study two processes: ion and fluid transport by the choroid plexus (focusing on the NKCC1 transporter) and how macrophages clear blood from the brain's ventricles. The team will use laboratory and developmental models plus analysis of relevant samples to see if altering these processes reduces cerebrospinal fluid accumulation. Ultimately they aim to find targets for treatments that could prevent hydrocephalus and limit long-term brain injury.

Why it matters

Potential benefit: If successful, this work could lead to new treatments that reduce CSF buildup and lower the need for surgical shunts in infants with PHH.

How similar studies have gone: Prior basic and preclinical studies have suggested roles for NKCC1 and macrophage-mediated blood clearance in CSF dynamics, but translating these findings into proven therapies for PHH remains largely untested.

Where this research is happening

  • Boston Children's Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Lehtinen, Maria — Boston Children's Hospital
  • Study coordinator: Lehtinen, Maria

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.